Seqirus makes plans to transition to cell-based flu vaccine - Healio

Seqirus makes plans to transition to cell-based flu vaccine  Healio

Seqirus announced plans manufacture its influenza vaccine for the 2019-2020 season using an exclusively cell-based production process for the first time.